Akoya Biosciences, Inc.
NASDAQ:AKYA
2.49 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 18.814 | 23.164 | 18.35 | 26.487 | 25.215 | 23.521 | 21.41 | 21.219 | 18.852 | 17.894 | 16.894 | 16.158 | 13.476 | 13.071 | 12.212 | 12.908 | 9.954 | 8.56 | 11.021 |
| Cost of Revenue
| 7.09 | 9.778 | 9.971 | 11.741 | 9.939 | 11.405 | 9.117 | 9.173 | 7.945 | 7.553 | 6.798 | 5.932 | 5.023 | 4.937 | 4.807 | 5 | 3.92 | 3.29 | 4.325 |
| Gross Profit
| 11.724 | 13.386 | 8.379 | 14.746 | 15.276 | 12.116 | 12.293 | 12.046 | 10.907 | 10.341 | 10.096 | 10.226 | 8.453 | 8.134 | 7.405 | 7.908 | 6.034 | 5.27 | 6.696 |
| Gross Profit Ratio
| 0.623 | 0.578 | 0.457 | 0.557 | 0.606 | 0.515 | 0.574 | 0.568 | 0.579 | 0.578 | 0.598 | 0.633 | 0.627 | 0.622 | 0.606 | 0.613 | 0.606 | 0.616 | 0.608 |
| Reseach & Development Expenses
| 4.474 | 5.288 | 5.554 | 4.67 | 5.173 | 6.273 | 5.773 | 6.433 | 5.466 | 5.598 | 5.714 | 5.563 | 3.999 | 2.947 | 3.192 | 2.532 | 2.279 | 2.42 | 2.372 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 14.672 | 19.094 | 19.863 | 18.898 | 19.017 | 22.708 | 21.758 | 20.948 | 19.922 | 20.59 | 18.193 | 19.046 | 13.725 | 10.066 | 8.179 | 6.816 | 5.712 | 5.105 | 6.349 |
| Other Expenses
| 0.927 | 0.088 | -0.161 | -0.005 | -0.185 | -0.105 | 1.971 | 1.759 | 1.815 | 1.617 | 1.543 | -0.166 | -0.126 | -0.052 | -0.066 | 0.143 | 0.057 | -0.056 | -0.105 |
| Operating Expenses
| 20.073 | 24.382 | 25.417 | 23.568 | 24.19 | 30.828 | 29.502 | 29.14 | 27.203 | 27.805 | 25.45 | 25.983 | 18.968 | 14.112 | 12.38 | 10.371 | 8.962 | 8.447 | 9.62 |
| Operating Income
| -8.349 | -11.084 | -17.038 | -8.822 | -11.551 | -19.242 | -17.209 | -17.094 | -16.296 | -17.464 | -15.354 | -16.78 | -10.739 | -6.378 | -5.401 | -3.149 | -3.667 | -3.832 | -1.363 |
| Operating Income Ratio
| -0.444 | -0.479 | -0.929 | -0.333 | -0.458 | -0.818 | -0.804 | -0.806 | -0.864 | -0.976 | -0.909 | -1.038 | -0.797 | -0.488 | -0.442 | -0.244 | -0.368 | -0.448 | -0.124 |
| Total Other Income Expenses Net
| -2.14 | -2.018 | -1.836 | -2.002 | -1.35 | -1.543 | -1.337 | -1.807 | -1.198 | -1.081 | -0.823 | -1.01 | -0.889 | 0.809 | -2.687 | -2.571 | -0.626 | -0.714 | -0.742 |
| Income Before Tax
| -10.489 | -13.102 | -23.421 | -10.824 | -12.901 | -20.785 | -18.773 | -18.901 | -17.851 | -17.389 | -16.377 | -17.79 | -11.628 | -5.569 | -8.088 | -5.72 | -4.293 | -4.546 | -2.105 |
| Income Before Tax Ratio
| -0.558 | -0.566 | -1.276 | -0.409 | -0.512 | -0.884 | -0.877 | -0.891 | -0.947 | -0.972 | -0.969 | -1.101 | -0.863 | -0.426 | -0.662 | -0.443 | -0.431 | -0.531 | -0.191 |
| Income Tax Expense
| 0.044 | 0.047 | 0.063 | -0.022 | -0.015 | 0.018 | 0.029 | -0.026 | 0.021 | 0.106 | 0.022 | -0.117 | -0.011 | -0.006 | -0.006 | -0.026 | -0.009 | 0.039 | 0.038 |
| Net Income
| -10.533 | -13.149 | -23.484 | -10.802 | -12.916 | -20.803 | -18.802 | -18.875 | -17.872 | -17.495 | -16.399 | -17.673 | -11.617 | -5.563 | -8.082 | -5.694 | -4.284 | -4.585 | -2.143 |
| Net Income Ratio
| -0.56 | -0.568 | -1.28 | -0.408 | -0.512 | -0.884 | -0.878 | -0.89 | -0.948 | -0.978 | -0.971 | -1.094 | -0.862 | -0.426 | -0.662 | -0.441 | -0.43 | -0.536 | -0.194 |
| EPS
| -0.21 | -0.27 | -0.48 | -0.22 | -0.26 | -0.51 | -0.49 | -0.5 | -0.47 | -0.47 | -0.44 | -0.47 | -0.31 | -0.19 | -0.23 | -0.16 | -0.15 | -0.16 | -0.074 |
| EPS Diluted
| -0.21 | -0.27 | -0.48 | -0.22 | -0.26 | -0.51 | -0.49 | -0.5 | -0.47 | -0.47 | -0.44 | -0.47 | -0.31 | -0.19 | -0.23 | -0.16 | -0.15 | -0.16 | -0.074 |
| EBITDA
| -6.039 | -8.57 | -18.758 | -6.425 | -8.086 | -16.523 | -14.598 | -15.153 | -14.803 | -14.85 | -14.009 | -15.572 | -9.621 | -3.68 | -6.328 | -3.952 | -2.639 | -2.966 | -0.569 |
| EBITDA Ratio
| -0.321 | -0.37 | -0.817 | -0.254 | -0.507 | -0.69 | -0.678 | -0.697 | -0.773 | -0.899 | -0.817 | -0.9 | -0.697 | -0.375 | -0.328 | -0.1 | -0.191 | -0.27 | -0.193 |